# Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

> **NCT01855490** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 17 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT01855490
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01855490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01855490, "Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01855490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*